Skip to main content
Top
Published in: Annals of Surgical Oncology 3/2021

01-03-2021 | Care | Pancreatic Tumors

Predicting Positive Margins in Pancreatic Head Adenocarcinoma After Neoadjuvant Therapy: Investigating Disparities in Quality Care Using the National Cancer Database

Authors: Corey Suraci, MBS, Katelyn Young, BS, James Dove, BA, Mohsen Shabahang, MD, PhD, Joseph Blansfield, MD

Published in: Annals of Surgical Oncology | Issue 3/2021

Login to get access

Abstract

Background

In pancreatic cancer, surgical resection with neoadjuvant therapy improves survival, but survival relies significantly on the margin status of the resected tissue. This study aimed to develop a model that predicts margin positivity, and then to identify facility-specific factors that influence the observed-to-expected (O/E) ratio for positive margins among facilities.

Methods

This retrospective review analyzed patients in the National Cancer Database (2004–2016) with pancreatic head adenocarcinoma [tumor-node-metastasis (TNM) stage 1 or 2] who received neoadjuvant therapy for a pancreaticoduodenectomy. Logistic regression was used to develop a model that predicts margin positivity. This model then was used to identify outlier facilities with regard to the O/E ratio. Hospital volume was defined as the total number of pancreaticoduodenectomies per year.

Results

The study enrolled 4085 patients, and 16.8% of these patients had positive margins. Most of the patients (64%) had a tumor size of 2 to 4 cm, and approximately 51% of the patients did not have positive lymph nodes at resection. A logistic regression model showed that the predictors of positive margins after resection with neoadjuvant therapy were male sex, larger tumor size, and positive lymph nodes. This model was validated to yield a bootstrap-corrected concordance index of 0.632. The study calculated O/E ratios with the model, identifying 12 low- and 17 high O/E-ratio outlier facilities among 401 studied hospitals. The outlier hospitals did not differ in facility type (i.e., academic vs integrated network), but did differ significantly in terms of yearly hospital volume (low outlier of 20.6 vs high outlier of 10.7; p = 0.008).

Conclusions

An association of lower-volume facilities with higher than expected rates of positive margins was found to indicate a disparity in care. This disparity was identified via an O/E ratio as a quality indicator for facilities. Facilities can gauge the efficiency of their own practices by referencing their O/E ratios, and they also can improve their practices by analyzing the framework of low O/E-ratio facilities.
Literature
3.
go back to reference Badger SA, Brant JL, McClements J, et al. Role of surgery in pancreatic cancer: a 12-year review of patient outcome. Ulster Med J. 2010;79:70–5.PubMedPubMedCentral Badger SA, Brant JL, McClements J, et al. Role of surgery in pancreatic cancer: a 12-year review of patient outcome. Ulster Med J. 2010;79:70–5.PubMedPubMedCentral
8.
go back to reference Lam K. Risk-adjusted nomogram based on the National Cancer Database for predicting margin positivity for head of the pancreas adenocarcinoma. Society of Surgical Oncology 72nd Annual Cancer Symposium: Abstracts for Plenary and Parallel Sessions. Ann Surg Oncol. 2019;26:1–224. https://doi.org/10.1245/s10434-019-07174-5.CrossRef Lam K. Risk-adjusted nomogram based on the National Cancer Database for predicting margin positivity for head of the pancreas adenocarcinoma. Society of Surgical Oncology 72nd Annual Cancer Symposium: Abstracts for Plenary and Parallel Sessions. Ann Surg Oncol. 2019;26:1–224. https://​doi.​org/​10.​1245/​s10434-019-07174-5.CrossRef
10.
go back to reference Amin MB, Gress DM. AJCC cancer staging manual. 8th ed. Springer, New York, 2017.CrossRef Amin MB, Gress DM. AJCC cancer staging manual. 8th ed. Springer, New York, 2017.CrossRef
Metadata
Title
Predicting Positive Margins in Pancreatic Head Adenocarcinoma After Neoadjuvant Therapy: Investigating Disparities in Quality Care Using the National Cancer Database
Authors
Corey Suraci, MBS
Katelyn Young, BS
James Dove, BA
Mohsen Shabahang, MD, PhD
Joseph Blansfield, MD
Publication date
01-03-2021
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue 3/2021
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-020-08766-2

Other articles of this Issue 3/2021

Annals of Surgical Oncology 3/2021 Go to the issue